Autophagy- An emerging target for melanoma therapy [version 1; referees: 2 approved]
Melanoma accounts for only 5% of all cancers but is the leading cause of skin cancer death due to its high metastatic potential. Patients with metastatic melanoma have a 10-year survival rate of less than 10%. While the clinical landscape for melanoma is evolving rapidly, lack of response to therapi...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2016-07-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | http://f1000research.com/articles/5-1888/v1 |